Anhui Huaheng Biotechnology Co., Ltd.
Shanghai Stock ExchangeTotal Valuation
Anhui Huaheng Biotechnology Co., Ltd. carries a market capitalization of 4.07B, placing it among publicly traded companies globally. Its enterprise value stands at 9.42B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 4.07B |
| Enterprise Value | 9.42B |
Share Statistics
Anhui Huaheng Biotechnology Co., Ltd. currently has 250.12M shares outstanding.
| Shares Outstanding | 250.12M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Anhui Huaheng Biotechnology Co., Ltd. trades at a trailing price-to-earnings ratio of 52.35. The price-to-sales ratio is 3.06, and the price-to-book ratio stands at 5.86.
| PE Ratio | 52.35 |
| PS Ratio | 3.06 |
| PB Ratio | 5.86 |
| P/TBV Ratio | 3.28 |
| P/FCF Ratio | 10.93 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Anhui Huaheng Biotechnology Co., Ltd. trades at an EV/EBITDA multiple of 46.05 and an EV/FCF ratio of 12.07. The EV/Sales ratio of 3.55 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 46.05 provides insight into valuation relative to core operating earnings.
| EV / Sales | 3.55 |
| EV / EBITDA | 46.05 |
| EV / EBIT | 46.05 |
| EV / FCF | 12.07 |
Financial Position
Anhui Huaheng Biotechnology Co., Ltd. maintains a current ratio of 1.09, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 65.41, indicating elevated leverage, while an interest coverage ratio of 4.90 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.09 |
| Quick Ratio | 0.29 |
| Debt / Equity | 65.41 |
| Debt / EBITDA | 8.37 |
| Interest Coverage | 4.90 |
Financial Efficiency
Anhui Huaheng Biotechnology Co., Ltd. posts a return on equity of 11.88 and a return on invested capital of 4.88.
| Return on Equity (ROE) | 11.88 |
| Return on Assets (ROA) | 3.16 |
| Return on Invested Capital (ROIC) | 4.88 |
| Return on Capital Employed (ROCE) | 6.79 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 5.36 |
Taxes
Over the trailing twelve months, Anhui Huaheng Biotechnology Co., Ltd. has paid 9.77M in income taxes, reflecting an effective tax rate of 6.28.
| Income Tax | 9.77M |
| Effective Tax Rate | 6.28 |
Stock Price Statistics
Anhui Huaheng Biotechnology Co., Ltd.'s stock has declined approximately -50.78692% over the past 52 weeks. The 50-day moving average sits at 22.75, while the 200-day moving average is 30.95.
| Beta (5Y) | N/A |
| 52-Week Price Change | -50.78692% |
| 50-Day Moving Average | 22.75 |
| 200-Day Moving Average | 30.95 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Anhui Huaheng Biotechnology Co., Ltd. generated 2.65B in revenue and converted that into 154.70M in net income, yielding earnings per share of 0.57. EBITDA reached 204.55M, while operating income came in at 204.55M.
| Revenue | 2.65B |
| Gross Profit | 580.71M |
| Operating Income | 204.55M |
| Pretax Income | 155.48M |
| Net Income | 154.70M |
| EBITDA | 204.55M |
| EBIT | 204.55M |
| Earnings Per Share (EPS) | 0.57 |
Balance Sheet
Anhui Huaheng Biotechnology Co., Ltd. holds 379.27M in cash and equivalents against 1.71B in total debt, resulting in a net debt position of 1.03B. Total book value stands at 1.38B, with working capital of 124.49M providing operational flexibility.
| Cash & Cash Equivalents | 379.27M |
| Total Debt | 1.71B |
| Net Debt | 1.03B |
| Equity (Book Value) | 1.38B |
| Book Value Per Share | 5.41 |
| Working Capital | 124.49M |
Cash Flow
After subtracting -741.00M in capital expenditures, free cash flow totaled -741.00M - equivalent to -2.90 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -741.00M |
| Free Cash Flow | -741.00M |
| FCF Per Share | -2.90 |
Margins
Anhui Huaheng Biotechnology Co., Ltd. operates with a gross margin of 21.91, reflecting its pricing power and cost economics. The operating margin of 7.72 and net profit margin of 5.84 provide insight into operational efficiency.
| Gross Margin | 21.91 |
| Operating Margin | 7.72 |
| Pretax Margin | 5.87 |
| Profit Margin | 5.84 |
| EBITDA Margin | 7.72 |
Dividends & Yields
The company's payout ratio of 135.25 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.72 |
| Dividend Yield | N/A |
| Payout Ratio | 135.25 |
| Shareholder Yield | -6.64 |
| FCF Yield | 9.15 |
Scores
Anhui Huaheng Biotechnology Co., Ltd. posts an Altman Z-Score of 2.79, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.79 |